> SIFI S.p.A. and Knight Therapeutics Announce Canadian License Agreement for NETILDEX™
"The only thing worse than being blind is having sight but no vision."
Helen Keller

 
 
L'Oculista Italiano is an Ophthalmology journal, founded in 1968, publishing scientific articles, reviews and interviews with the aim to contribute to scientific and professional update of...
 
Focus On vision science related meetings & events around the world. To suggest a meeting or event to be published in this section please send an email stating event title, dates, subject...
 
SIFI Company Vision Video SIFI Press Conference "Integrated innovations to support the visually impaired" SIFI Diary from ESCRS 2015 with ¡Hasta la Vista SIFI!...

On our Social Channels

From our News Center

SIFI, the main Italian ophthalmic pharmaceutical company, is actively involved in the fight against COVID-19, and is alongside physicians, nurses and health personnel, to help face together the...
 

 

23 October

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading Canadian specialty pharmaceutical company, and SIFI S.p.A. (“SIFI”), a prominent Italian...
Follow Us!